Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 9,019 shares at $9.50 ($86K) on 2024-05-28, disclosed to the SEC on 2024-05-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |